中文 | English
Return
Total: 353 , 1/36
Show Home Prev Next End page: GO
MeSH:(Antineoplastic Combined Chemotherapy Protocols/*adverse effects)

1.Single-center study of different treatment for advanced or unresectable angiosarcoma patients.

Rui Qing PENG ; Bu Shu XU ; Yuan Yuan LIU ; Qian Qiong YANG ; Qiu Zhong PAN ; Xing ZHANG

Chinese Journal of Oncology 2023;45(1):74-81

2.Combination of anlotinib and irinotecan in the second-line treatment of metastatic colorectal cancer: a multicenter phase 1/2 trial.

Bo ZHANG ; Xi WANG ; Ling Jun ZHU ; Wei You ZHU ; Qun LI ; Yun LIU ; Ling QI ; Yong Qian SHU ; Jing HUANG

Chinese Journal of Oncology 2023;45(1):95-100

4.Safety and efficacy analysis on modified FOLFOXIRI as first-line treatment for advanced colorectal cancer in China-single center experience.

Yue CAI ; Huabin HU ; Wenjing WANG ; Taiyuan CAO ; Yanhong DENG

Chinese Journal of Gastrointestinal Surgery 2014;17(11):1081-1086

6.Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis.

Wen Qian WANG ; Jian GE ; Hong Hao MA ; Hong Yun LIAN ; Lei CUI ; Li ZHANG ; Zhi Gang LI ; Tian You WANG ; Rui ZHANG

Chinese Journal of Pediatrics 2023;61(12):1118-1123

7.Consensus on clinical diagnosis, treatment, and prevention of chemotherapy-induced neutropenia in China (2023 edition).

Chinese Journal of Oncology 2023;45(7):575-583

8.Hepatitis B Reactivation During Adjuvant Anthracycline-Based Chemotherapy in Patients with Breast Cancer: A Single Institution's Experience.

Min Kyoung KIM ; Jin Hee AHN ; Sung Bae KIM ; Young Suk IM ; Soon Im LEE ; Sei Hyun AHN ; Byung Ho SON ; Gyungyub GONG ; Hak Hee KIM ; Woo Kun KIM

The Korean Journal of Internal Medicine 2007;22(4):237-243

9.Clinical efficacy of CCG7942/POG9354 protocol in treatment of peripheral primitive neuroectodermal tumor in children.

Kui-Yao QU ; Suo-Qin TANG ; Chen FENG ; Ying LIU

Chinese Journal of Contemporary Pediatrics 2014;16(11):1109-1113

10.Oral combination chemotherapy of 5'-deoxy-5-fluorouridine (furtulon) and cyclophosphamide for advanced breast cancer.

Bing-he XU ; Ying-juan ZHANG ; Xiao ZHENG ; Qing WU ; Xiao-ting WU

Chinese Journal of Oncology 2003;25(3):282-284

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 353 , 1/36 Show Home Prev Next End page: GO